The contract regulatory affairs-management services market for medical devices is estimated

In order to reduce risk of device recalls and expedite time to market, medical device developers rely on contract service providers for regulatory submissions and navigating various challenging aspects of the product review and approval process
Spread the Word
Listed Under

* Research

* Biotech

* Alhambra - California - US

* Reports

ALHAMBRA, Calif. - March 17, 2020 - PRLog -- Roots Analysis has announced the addition of "Contract Regulatory Affairs-Management Market for Medical Devices, 2019-2030" report to its list of offerings.

More than 130 medical devices were approved by the FDA since January 2018, while several are currently being evaluated across more than 9,500 (active) clinical trials, worldwide. Even though technical innovation has enabled the development of a variety of versatile medical devices, product approval, given stringent regulatory standards, is still a concern.

Key Market Insights

Over 400 CROs claim to offer regulatory affairs-management services for medical devices
Of these, over 40% players provide the aforementioned services for all device classes. Further, the market is characterized by the presence of companies of all sizes; it is also worth noting that very small and small companies are solely comprised of more than 50% of the competitive landscape.

About 30% of companies have elaborate service portfolios, offering end-to-end solutions
Most players (78%) offer assistance in regulatory document submissions; other popular services (in terms of number of companies offering them) include vigilance and medical device reporting (74%), followed by technical dossier set-up (72%), product registration and clinical trial applications (67%), risk management-related services (65%), and regulatory writing and publishing (59%).

60% CROs offer support for launching medical devices in developed regions
Majority of the service providers are experienced in enabling their sponsors to have their products launched in the US and are capable of efficiently navigating the regulatory framework established by the US FDA. Regarding developing regions, many CROs presently claim to be familiar with the regulatory environments in China (18%), Australia (16%) and India (13%).

To request a sample copy / brochure of this report, please visit this link

The report features inputs from eminent industry stakeholders, according to whom, presently, regulatory affairs management, clinical trial site selection, trial monitoring and project management are the activities outsourced by most of the sponsor companies. Further, the requirement for highly experienced personnel for conducting such activities has compelled developers to outsource their regulatory affairs management operations, since most of the players are inherently inexperienced in navigating through the complex regulatory frameworks. The report includes detailed transcripts of discussions held with the following experts:

For additional details, please visit

or email (

Gaurav Chaudhary
+1 (415) 800 3415 (

Roots Analysis
Posted By:*** Email Verified
Location:Alhambra - California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Roots Analysis News
Most Viewed
Daily News

Like PRLog?
Click to Share